Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
ZL
Zhean Li
Author with expertise in Therapeutic Antibodies: Development, Engineering, and Applications
Achievements
Open Access Advocate
Key Stats
Upvotes received:
0
Publications:
2
(50% Open Access)
Cited by:
7
h-index:
4
/
i10-index:
3
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
2
Peer Reviews
Comments
Grants
Publications
10
Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago
Min Qiang
et al.
Nov 6, 2020
ABSTRACT Combinatorial antibody libraries not only effectively reduce antibody discovery to a numbers game, but enable documentation of the history of antibody responses in an individual. The SARS-CoV-2 pandemic has prompted a wider application of this technology to meet the public health challenge of pandemic threats in the modern era. Herein, we used a combinatorial human antibody library constructed 20 years before the COVID-19 pandemic to discover three highly potent antibodies that selectively bind SARS-CoV-2 spike protein and neutralize authentic SARS-CoV-2 virus. Compared to neutralizing antibodies from COVID-19 patients with generally low somatic hypermutation (SHM), these antibodies contain over 13-22 SHMs, many of which are involved in specific interactions in crystal structures with SARS-CoV-2 spike RBD. The identification of these somatically mutated antibodies in a pre-pandemic library raises intriguing questions about the origin and evolution of human immune responses to SARS-CoV-2.
Genetics
Oncology
10
Paper
Genetics
7
0
Save
0
Viral N protein hijacks deaminase-containing RNA granules to enhance SARS-CoV-2 mutagenesis
Zhean Li
et al.
Nov 20, 2024
Genetics
Molecular Biology
0
Paper
Genetics
Molecular Biology
0
Save